Thermography Policy
Policy defines coverage stance for thermography (digital infrared thermography and related techniques) for BlueCHiP for Medicare and Commercial products; states thermography is considered not medically necessary due to insufficient evidence and gives billing guidance to report with an unlisted cardiovascular code.
States that all forms of thermography are considered not medically necessary due to insufficient evidence.
Coverage Summary
The policy applies to thermography (digital infrared thermography and related techniques) for BlueCHiP for Medicare and Commercial products. The use of all forms of thermography is considered not medically necessary because evidence is insufficient to determine effects on health outcomes. Evidence supporting this stance includes multiple references and reviews concluding insufficient clinical utility (see references).